Company
Matchpointtx
Matchpoint is discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.
Also known as Matchpoint Therapeutics, Matchpoint Therapeutics, Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Watertown, MA, United States
- Legal name
- Matchpoint Therapeutics, Inc
- matchpointtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 22 October 2026
About
Matchpoint is a privately held biotechnology company harnessing the power of covalency to discover precision oral medicines to transform the treatment of immune diseases.
Funding snapshot
- Total raised
- $42MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series B, $150M2026-10-09
Funding rounds
- Series B
- $150M2026-10-09, Announced
- Round, 2022
- $42M2022-10-05, SEC form D sold, 15 investors
Loading relationship preview